1. Home
  2. NUS vs IGMS Comparison

NUS vs IGMS Comparison

Compare NUS & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUS
    SELLHOLDBUYas of 6 hours ago
  • IGMS
    SELLHOLDBUYas of 6 hours ago
  • Stock Information
  • Founded
  • NUS 1984
  • IGMS 1993
  • Country
  • NUS United States
  • IGMS United States
  • Employees
  • NUS N/A
  • IGMS N/A
  • Industry
  • NUS Other Pharmaceuticals
  • IGMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NUS Health Care
  • IGMS Health Care
  • Exchange
  • NUS Nasdaq
  • IGMS Nasdaq
  • Market Cap
  • NUS 321.6M
  • IGMS 82.1M
  • IPO Year
  • NUS 1996
  • IGMS 2019
  • Fundamental
  • Price
  • NUS $7.91
  • IGMS $1.34
  • Analyst Decision
  • NUS Hold
  • IGMS Hold
  • Analyst Count
  • NUS 2
  • IGMS 8
  • Target Price
  • NUS $6.88
  • IGMS $6.14
  • AVG Volume (30 Days)
  • NUS 834.8K
  • IGMS 266.8K
  • Earning Date
  • NUS 02-13-2025
  • IGMS 03-10-2025
  • Dividend Yield
  • NUS 2.99%
  • IGMS N/A
  • EPS Growth
  • NUS N/A
  • IGMS N/A
  • EPS
  • NUS N/A
  • IGMS N/A
  • Revenue
  • NUS $1,732,084,000.00
  • IGMS $2,918,000.00
  • Revenue This Year
  • NUS N/A
  • IGMS $26.85
  • Revenue Next Year
  • NUS $3.65
  • IGMS $132.72
  • P/E Ratio
  • NUS N/A
  • IGMS N/A
  • Revenue Growth
  • NUS N/A
  • IGMS 57.64
  • 52 Week Low
  • NUS $5.95
  • IGMS $1.26
  • 52 Week High
  • NUS $14.04
  • IGMS $22.50
  • Technical
  • Relative Strength Index (RSI)
  • NUS 62.66
  • IGMS 25.95
  • Support Level
  • NUS $7.72
  • IGMS $1.29
  • Resistance Level
  • NUS $8.18
  • IGMS $1.44
  • Average True Range (ATR)
  • NUS 0.52
  • IGMS 0.11
  • MACD
  • NUS 0.12
  • IGMS 0.16
  • Stochastic Oscillator
  • NUS 44.88
  • IGMS 13.83

Stock Price Comparison Chart: NUS vs IGMS

NUS
IGMS
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100NUS VS IGMS

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

About IGMS IGM Biosciences Inc.

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use